Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

Inhibition of Growth of Streptococcus mutans, Methicillin-Resistant Staphylococcus aureus, and Vancomycin-Resistant Enterococci by Kurarinone, a Bioactive Flavonoid Isolated from Sophora flavescens

Li Chen, Xiaofang Cheng, Wenyuan Shi, Qingyi Lu, Vay Liang Go, David Heber, Lili Ma
Li Chen
School of Dentistry and Dental Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaofang Cheng
School of Dentistry and Dental Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenyuan Shi
School of Dentistry and Dental Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wenyuan@ucla.edu
Qingyi Lu
UCLA Center for Human Nutrition University of California Los Angeles, CA 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vay Liang Go
UCLA Center for Human Nutrition University of California Los Angeles, CA 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Heber
UCLA Center for Human Nutrition University of California Los Angeles, CA 90095
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lili Ma
Department of Dermatology Zhejiang Hospital of Chinese Medicine Hangzhou, 310006, People's Republic of China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.43.7.3574-3575.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Infectious diseases caused by pathogenic bacteria have been the leading cause of morbidity and mortality in human history. The discovery of the antibacterial compound from the mold Penicillium notatum by Alexander Fleming led to the development of antibiotics, which are still the main weapons for combating the deadly bacterial infections at the present time. However, over 60 years of application of antibiotics leads to the development of antibiotic resistance of many bacterial pathogens. Consequently, bacterial infections have again become the most common and deadly causes of human diseases. Two of the most lethal hospital infections are caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) (10). Furthermore, Streptococcus mutans-associated tooth decay is one of the most prevalent and costly infectious diseases in the United States (4, 11; http://www.surgeongeneral.gov/library/oralhealth/ ).

The emergence of both “new pathogens” and resistant strains from “old pathogens” demands new antibacterial compounds to deal with this crisis. Given the fact that most commonly used antibiotics are isolated from microorganisms, it is important to search for new antibacterial compounds from new bio-resources. Chinese medicinal herbs are logical choices due to their proven ability to treat microbial infections. In traditional Chinese medicine (TCM) practice, a group of herbs has been widely used for a specific therapeutic application defined as Qing Re Jie Du (Embedded Image), or “alleviating heat and relieving the symptoms caused by toxins” (2, 3). Many herbs in this category have been found to have antimicrobial activities (2, 3). Recently, we conducted a systematic screen of herbs with Qing Re Jie Du function for the inhibitory activities against S. mutans, the primary etiological agent for dental caries and other pathogens (1), and found that the extract made from Sophora flavescens contains a potent bioactivity against S. mutans, MRSA, and VRE.

S. flavescens is a perennial shrub found in Northeast Asia (Fig. 1A). It grows in sandy soils on mountain slopes or river valleys. In spring or autumn, the roots are collected, cleaned, sliced, and air-dried. The processed root of S. flavescens is also known as “Ku Shen,” which means “a precious medicinal root with bitter taste” (Fig. 1B). In more than 1,000 years of TCM practice, it has being used to treat pyretic and analgesic symptoms (http://www.itmonline.org/arts/sophora.htm ). Although a variety of bioactive compounds have been recently isolated from S. flavescens for the treatment of inflammation, cancer, and cardiovascular disorders (5, 13), the knowledge about its antibacterial potential is limited (7).

To study the active antimicrobial component(s) in S. flavescens, the following procedures were followed. First, an extract of S. flavescens was prepared according to a previously published extraction method (1), and its MIC against S. mutans was determined with a protocol recommended by the National Committee of Clinical Laboratory Standards (NCCLS) (9) (Table 1). Following the bioassay, the extract was then chromatographed over silica gel (100- to 200-mesh; Selecto, Georgia), and eluted with a hexane:ethyl gradient acetate. Equal volumes of the eluted solutions were collected, dried by evaporation, and subjected to the antimicrobial assay to track down the most active fraction(s). Following the bioassay, the chemical composition of active fractions was then analyzed by thin-layer chromatography and high-performance liquid chromatography (HPLC). The result indicated that the most active fraction contains ∼80% of the active compound. Further purification was performed on semipreparative HPLC equipment (600E system controller and 996 photodiode array detector; Waters, Milford, MA) equipped with a reverse-phase C18 column (7.8 by 300 mm). The homogeneity of the purified active compound (>95%) was established by both HPLC profiles (data not shown) and subsequent 1H nuclear magnetic resonance (NMR) spectra (500 MHz) (Fig. 2).

The purified compound was then analyzed by mass spectrometer and NMR spectroscopy (1H and 13C), respectively. Based on the extensive one- and two-dimensional (1D and 2D)NMR spectroscopic interpretation and mass spectrometer analysis (data not shown), we concluded that the isolated active compound is kurarinone, a known compound isolated from S. flavescens (5, 7, 8, 13). Kurarinone is a flavonoid with a lavandulyl side chain, and its chemical structure is illustrated in Fig. 3.

Several bioactivities of kurarinone have been previously reported, including antifungal activities against Candida albicans and Cladosporium cucumerinum(12), antimalarial activity (6), cytotoxic activity against human tumor cells (myeloid leukemia HL-60 cells) (5), and COX-1 inhibitory activity (5). At the current stage, the molecular mechanisms of its action in both pathogens and mammalian cells are largely unknown. In this study, a strong antibacterial activity of kurarinone was detected. Its MICs against S. mutans and multidrug-resistant strains (MRSA and VRE) are at the same level (2 μg/ml) (Table 1). Time- and dose-dependent bactericidal effects of kurarinone against S. mutans (Fig. 3B), MRSA, and VRE (data not shown) were also detected. These data suggested a potential application of kurarinone for the treatment of diseases or conditions associated with S. mutans, MRSA, and VRE.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Sophora flavescens (A) and its dried roots (Ku Shen) (B) used in TCM application.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Proton-NMR spectrum of purified kurarinone.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

Kurarinone (A) and its time- and dose-dependent bactericidal effect against S. mutans (B). The chemical structure of kurarinone was elucidated on the basis of extensive 1D and 2D NMR spectroscopic interpretation. The killing effect of kurarinone was determined by counting the colony formation units on the plates after the cells were treated with the conditions illustrated in panel B.

View this table:
  • View inline
  • View popup
TABLE 1.

Susceptibility of S. mutans, MRSA, and VRE to antimicrobial compounds and kurarinone

ACKNOWLEDGMENTS

This study was supported by a grant from C3 Scientific Corporation and Biostar to W. Shi, NIH grant AT00151 to D. Heber, and a New Investigator Award from NIH to L. Chen.

We thank Dr. William H. Benjamin for providing MRSA and VRE strains used in this study. We express our appreciation and gratitude to Dr. Fengxia Qi, Dr. Jian He, and Charles Xiao Fong Zhou for their suggestions and comments on the manuscript. We also thank Dr. Fang Gu and Dr. Larry Wolinsky for their helpful discussions.

  • Copyright © 2005 American Society for Microbiology

REFERENCES

  1. 1.↵
    Chen, L., L. Ma, N. H. Park, and W. Shi. 2001. Cariogenic actinomyces identified with a β-glucosidase-dependent green color reaction to Gardenia jasminoides extract. J. Clin. Microbiol.39:3009-3012.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Chen, Q. 1998. Pharmacology and clinical applications of classical TCM formulas. People's Publisher, Beijing, People's Republic of China.
  3. 3.↵
    Huang, T. K. 1994. A handbook of the composition and pharmacology of common Chinese drugs. China Medical Science and Technology, Beijing, People's Republic of China.
  4. 4.↵
    Johnson, N. W. 1991. Risk markers for oral diseases. 1. Dental Caries. Cambridge University Press, Cambridge, England.
  5. 5.↵
    Kang, T. H., S. J. Jeong, W. G. Ko, N. Y. Kim, B. H. Lee, M. Inagaki, T. Miyamoto, R. Higuchi, and Y. C. Kim. 2000. Cytotoxic lavandulyl flavanones from Sophora flavescens. J. Nat. Prod.63:680-681.
    OpenUrlPubMed
  6. 6.↵
    Kim, Y. C., H. S. Kim, Y. Wataya, D. H. Sohn, T. H. Kang, M. S. Kim, Y. M. Kim, G. M. Lee, J. D. Chang, and H. Park. 2004 . Antimalarial activity of lavandulyl flavanones isolated from the roots of Sophora flavescens. Biol. Pharm. Bull.27:748-750.
    OpenUrlPubMed
  7. 7.↵
    Kuroyanagi, M., T. Arakawa, Y. Hirayama, and T. Hayashi. 1999. Antibacterial and antiandrogen flavonoids from Sophora flavescens. J. Nat. Prod.62:1595-1599.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Lee, H. O., N. K. Park, S. I. Jeong, Y. C. Kim, and S. H. Baek. 2001. Isolation of antimicrobial compounds from the ethyl acetate extract of Sophora flavescens. Yakhak Hoe Chi45:588-590.
    OpenUrl
  9. 9.↵
    NCCLS. 2003 . Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 6th ed. NCCLS, Wanye, Pa.
  10. 10.↵
    Russell, A. D. 2002. Antibiotic and biocide resistance in bacteria: introduction. J. Appl. Microbiol.92(Suppl.):1S-3S.
    OpenUrlCrossRef
  11. 11.↵
    Satcher, D. 2000. Oral health in America: a report of the surgeon general-executive summary. U.S. Department of Health and Human Services, Washington, D.C.
  12. 12.↵
    Tan, R. X., J. L. Wolfender, L. X. Zhang, W. G. Ma, N. Fuzzati, A. Marston, and K. Hostettmann. 1996. Acyl secoiridoids and antifungal constituents from Gentiana macrophylla. Phytochemistry42:1305-1313.
    OpenUrlPubMed
  13. 13.↵
    Zheng, Y., J. Yao, X. Shao, and N. Muralee. 1999. Bio-active compounds from Sophora flavescens Ait. Nongyaoxue Xuebao.1:91-93.
    OpenUrl
PreviousNext
Back to top
Download PDF
Citation Tools
Inhibition of Growth of Streptococcus mutans, Methicillin-Resistant Staphylococcus aureus, and Vancomycin-Resistant Enterococci by Kurarinone, a Bioactive Flavonoid Isolated from Sophora flavescens
Li Chen, Xiaofang Cheng, Wenyuan Shi, Qingyi Lu, Vay Liang Go, David Heber, Lili Ma
Journal of Clinical Microbiology Jul 2005, 43 (7) 3574-3575; DOI: 10.1128/JCM.43.7.3574-3575.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Growth of Streptococcus mutans, Methicillin-Resistant Staphylococcus aureus, and Vancomycin-Resistant Enterococci by Kurarinone, a Bioactive Flavonoid Isolated from Sophora flavescens
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Inhibition of Growth of Streptococcus mutans, Methicillin-Resistant Staphylococcus aureus, and Vancomycin-Resistant Enterococci by Kurarinone, a Bioactive Flavonoid Isolated from Sophora flavescens
Li Chen, Xiaofang Cheng, Wenyuan Shi, Qingyi Lu, Vay Liang Go, David Heber, Lili Ma
Journal of Clinical Microbiology Jul 2005, 43 (7) 3574-3575; DOI: 10.1128/JCM.43.7.3574-3575.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Enterococcus
Flavonoids
methicillin resistance
Staphylococcus aureus
Streptococcus mutans
vancomycin resistance

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X